TOMI Selected by Espire Health to Deploy SteraMist Platform in New Health Facilities in the Philippines

BEVERLY HILLS, Calif., Jan. 06, 2016 (GLOBE NEWSWIRE) -- TOMI™ Environmental Solutions, Inc. (OTCQB:TOMZ) (TOMI), a global bacteria decontamination and infection prevention company, received an order for its SteraMist™ Surface Unit from Espire Health, an existing SteraMist customer. Espire Health plans to use deploy SteraMist in new facilities being opened across the Philippines.

This order, valued at approximately $500,000, expands TOMI and Espire Health’s existing program to combat issues such as tuberculosis resistance within healthcare facilities.

Dr. Halden Shane, TOMI’s Chief Executive Officer, stated: “We are pleased to continue our relationship with Espire Health as we believe this additional order for SteraMist demonstrates the value our products provide to customers and validates the effectiveness of our technologies in a variety of applications. Over the past year, we have significantly expanded the footprint of our products both domestically and internationally as SteraMist is quickly establishing a reputation for its advantages in speed and efficacy over competing household and industrial cleaners. In this application specifically, the need for such a product is quite evident as the Philippines has among the world’s highest cases of TB resistance.”

TOMI’s has a five-second application time for room surfaces and a seven-minute contact time, the fastest of all mechanical cleaning healthcare agents. The mist produced by BIT dries rapidly on contact, does not contain or produce toxins or harsh chemicals such as chlorine hypochlorite (bleach), aldehydes, phenols, ammonium compounds, sodium hydroxide, or contain silver.

About TOMI^™ Environmental Solutions, Inc.
TOMI^™ Environmental Solutions, Inc. (OTCQB:TOMZ) is a global bacteria decontamination and infectious disease control company, providing eco-friendly environmental solutions for indoor surface decontamination through manufacturing, sales and licensing of our premier platform of Hydrogen Peroxide based products that uses Binary Ionization Technology® (BIT^™), a state of the art technology for the production of its six-log mist represented by the TOMI™ SteraMist™ brand.

TOMI’s products are designed to service a broad spectrum of commercial structures including hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, for non-food safety in meat and produce processing facilities, military barracks, and athletic facilities. TOMI’s products and services have also been used in single-family homes and multi-unit residences.

TOMI also develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, The Restoration Industry Association, Indoor Air Quality Association, and The International Ozone Association. For additional product information, visit www.tomiesinc.com or contact us at [email protected].

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
Certain written and oral statements made by us may constitute “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). Forward-looking statements are identified by such words and phrases as “we expect,” “expected to,” “estimates,” “estimated,” “current outlook,” “we look forward to,” “would equate to,” “projects,” “projections,” “projected to be,” “anticipates,” “anticipated,” “we believe,” “could be,” and other similar phrases. All statements addressing operating performance, events, or developments that we expect or anticipate will occur in the future, including statements relating to revenue growth, earnings, earnings-per-share growth, or similar projections, are forward-looking statements within the meaning of the Reform Act. They are forward-looking, and they should be evaluated in light of important risk factors that could cause our actual results to differ materially from our anticipated results. The information provided in this document is based upon the facts and circumstances known at this time. We undertake no obligation to update these forward-looking statements after the date of this release.

INVESTOR RELATIONS CONTACT:
Becky Herrick & Kirsten Chapman
LHA (IR Agency)
(415) 433-3777
[email protected]

MEDIA RELATIONS CONTACT:
Aaron Loveland
VP of Marketing and Public Affairs
(240) 672-6263
[email protected]